Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 5, Number 6, December 2013, pages 426-431


Co-Infections in Children Hospitalised for Bronchiolitis: Role of Roomsharing

Tables

Table 1. Dyspnoea Score
 
012
Adapted from Kristiansson [27].
Respiratory ratenormal < 40/minslightly increased 40 - 60/minclearly increased > 60/min
Oxygen saturation≥ 95% in room air92-94% in room air< 92% in room air, or need for supplemental oxygen
Wheezingnoneaudible with stethoscopeaudible without stethoscope
Retractionsnonemild-moderatesevere
General conditionnot affected:
alert/quietly sleeping
moderately affected:
Irritable or agitated
severely affected:
lethargic, poor feeding

 

Table 2. Patient Characteristics
 
Data are presented as median and interquartile range in parentheses, or number and percentage in parentheses; Highest possible dyspnoea score 10; * all 3 patients mono-infected with RSV.
n = 48
Age, months3.2 (1.8 - 9.7)
Male26 (54.2%)
Birth characteristics
  gestational age, weeks38.5 (37.8 - 40.1)
  preterm birth (< 37 weeks)2 (4.2%)
  birth weight, gram3420 (3,120 - 3,740)
Environmental factors
  day care attendance16 (33.3%)
  siblings39 (81.2%)
Disease severity
  length of hospitalization (days)1.9 (1.6 - 4.0)
  oxygen supplementation30 (62.5%)
  tubefeeding20 (41.7%)
  highest dyspnoea score (0-10)3.0 (2.0 - 4.8)
  mechanical ventilation3* (6.2%)

 

Table 3. Distribution of Viral Pathogens
 
VirusAt admission
n = 48
At discharge
n = 48
After discharge
n = 44
Number with percentage in parentheses; RSV: Respiratory Syncytial; hMPV: human MetaPneumo Virus; RhV: Rhino Virus; CoV: Corona Virus; AdV: Adeno Virus; PIV: Parainfluenza Virus.
Mono-infections
  RSV-A7 (14.5%)6 (12.5%)2 (4.5%)
  RSV-B25 (52.1%)19 (39.6%)5 (11.4%)
  hMPV2 (4.2%)1 (2.1%)1 (2.3%)
  RhV3 (6.3%)3 (.3%)3 (6.8%)
  CoV02 (4.2%)1 (2.3%)
  AdV003 (6.8%)
Co-infections
RSV-A and hMPV1 (2.1%)1 (2.1%)0
RSV-B and
  PIV1 (2.1%)00
  AdV01 (2.1%)0
  RhV4 (8.3%)4 (8.3%)1 (2.3%)
  CoV1 (2.1%)00
  hMPV1 (2.1%)1 (2.1%)0
CoV and PIV1 (2.1%)1 (2.1%)0
No virus2 (4.2%)9 (18.8%)28 (63.6%)

 

Table 4. Comparison of Disease Severity Between Mono- Versus Co-Infected Patients and RSV-Infected Versus RSV-Uninfected Patients
 
n = 48Mono versus co-infectionRSV-infected versus RSV-uninfected
Co-infection
n = 11
Mono-infection
n = 37
P-valueRSV-infected
n = 40
RSV-uninfected
n = 8
P-value
Data are presented as median and interquartile range in parentheses, or number and percentage in parentheses as appropriate; P value: Mann-Whitney-U test for continuous variables, χ2 test for dichotomous variables.
Age, months4.3 (2.2 - 11.4)3.2 (1.6 - 9.4)0.4133.3 (1.8 - 9.8)3.0 (1.6 - 8.5)0.740
Length of hospitalization, days2.0 (1.7 - 3.4)1.9 (1.2 - 4.2)0.8642.5 (1.6 - 4.4)1.8 (1.2 - 1.9)0.162
Oxygen supplementation6 (54.6%)24 (64.9%)0.53525 (62.5%)5 (62.5%)1.000
Tubefeeding4 (36.4%)16 (43.2%)0.68118 (45.0%)2 (25%)0.295
Highest dyspnoea score (0-10)3.0 (2.0 - 4.0)3.0 (1.5 - 5.0)0.6543.0 (2.0 - 5.0)2.5 (1.0 - 4.0)0.285
Mechanical ventilation1 (9.1%)2 (5.4%)0.6583 (7.5%)0 (0%)0.424